Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 82009-174
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metformin Hydrochloride (NDC 82009-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
500 mg (D40fc88c Ea7d 44c2 87d5 B751b676602e 02)
This text provides the description of Metformin Hydrochloride tablets, USP containing 500 mg of the active ingredient. It gives information on dosage, storage conditions, and manufacturer details. It is advised to refer to the package insert for full prescribing information and to store the tablets at a temperature of 20°C to 25°C. The tablets should be dispensed in a light-resistant container and kept out of reach of children. The manufacturer details include Zyudus Lifesciences Ltd. in India, and the tablets are manufactured for Quallent Pharmaceuticals Health LLC in Grand Cayman, Cayman Islands.*
1,000 mg (D40fc88c Ea7d 44c2 87d5 B751b676602e 03)
This text provides information about Metformin Hydrochloride tablets, USP, with each film-coated tablet containing 1,000 mg of the active ingredient. It also includes details about dosage and storage. The tablets are manufactured by Zydus Lifesciences Ltd. in India and produced for Qualent Pharmaceuticals Health LLC in Grand Cayman, Cayman Islands. Please refer to the package insert for complete prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.